News Archive

/static/apps/cms/news/1587/images/banners/Mire and Cho header image.png

Coming Full Circle Leads to a New Path Forward

October 28, 2024 / Phd Program

Dr. David Cho's intersection with MCP Graduate Student Leads to a New Career Path

FULL STORY
/static/apps/cms/news/1580/images/banners/Brian Harry Header Image.png

Chemistry and Aging Research

October 10, 2024 / Faculty Spotlight

Dr. Brian Harry finds the right combination at Michigan

FULL STORY
/static/apps/cms/news/1576/Nunez, Gabriel 500.jpg

New Uses for Common Drug May Help Patients with Inflammatory Diseases

September 19, 2024 / Experimental Pathology

An article recently published by the Nuñez lab provides an exciting discovery for individuals with Alzheimer’s disease, diabetes, and certain other autoimmune diseases caused by aberrant NLRP3. The research, led by Dr. Jie Xu with Drs. Joseph Pickard and Gabriel Nuñez, discovered that a common, safe, FDA-approved drug used to treat alcoholism and cocaine addictions, disulfiram, inhibits the production of NLRP3 inflammasomes. When NLRP3 is activated, it can cause inflammation leading to multiple health issues.

FULL STORY
/static/apps/cms/news/1535/Nesvizhskii and Dhanasekaran.png

Large study identifies biomarkers for rare kidney tumors

May 15, 2024 / Experimental Pathology

With 20 subtypes of Renal Cell Carcinoma (RCC) listed by the World Health Organization in 2022, determining the specific type of RCC and the correct treatment protocol for patients can be daunting. Only seven of the 20 subtypes had been defined by specific molecular changes and the 20% of RCCs that are classified as non-clear cell RCCs (non-ccRCC), were primarily identified only by histopathologic features. The driving genetic changes had not been identified. A large multi-institutional team making up the Clinical Proteomic Tumor Analysis Consortium, including several researchers from Michigan Medicine’s Department of Pathology, performed multi-omics data analysis on 48 non-ccRCC and 103 ccRCC tumors as well as 101 normal adjacent tissues to study the genetic aberrations found in these tumor types. The findings of this research were recently published in Cell Reports Medicine, with Pathology’s Drs. Alexey Nesvizhskii and Saravana Mohan Dhanasekaran as senior authors and Dr. Ginny Xiaohe Li as first author.

FULL STORY
/static/apps/cms/news/1527/Rozumek, Gabrielle 2021_04_09 cropped 500.jpg

MCP Student Gabbi Rozumek awarded 2024 Phyllis M. Wise Biomedical Sciences Graduate Student Award for Excellence in Service

April 12, 2024 / Award

The MCP team is proud to share the news that MCP student Gabrielle "Gabbi" Rozumek is the recipient of the 2024 Phyllis M. Wise Biomedical Sciences Graduate Student Award for Excellence in Service.

Gabbi is very passionate about and dedicated to serving her community. Since 2016, she has touched so many lives by serving in numerous and various capacities. A few of her efforts include:

FULL STORY
/static/apps/cms/news/1526/Nick Lukacs and James Baker Jr.jpg

Mary H. Weiser Food Allergy Center Identified as an Elite Research Center

April 11, 2024 / Experimental Pathology

An interdisciplinary team of researchers from across Michigan Medicine are focused on cutting-edge research to understand and address food allergies as members of the Mary H. Weiser Food Allergy Center. Nicholas Lukacs, PhD, the Godfrey Dorr Stobbe Professor of Pathology and Scientific Director of the Mary H. Weiser Food Allergy Center, and James R. Baker Jr., Ruth Dow Doan Professor of Biologic Nanotechnology and Director of the MHWFAC, were instrumental in founding the food allergy center in 2015 and in recruiting an exceptional team of researchers to the Center. One of their goals since the inception of the MHWFAC was to see it become recognized as one of the world’s elite research centers in its field. Recently, this goal was achieved when the National Institutes of Health awarded them one of just 10 seven-year CoFAR Cooperative Agreement Grants, recognizing the center’s exceptional ground-breaking research.

FULL STORY
/static/apps/cms/news/1511/images/banners/Untitled-1.jpg

Giving Blueday-March 13, 2024

March 4, 2024 / Announcement
This Giving Blueday (March 13, 2024) support key initiatives within the Department of Pathology which help support the next generation of trainees, researchers, and physicians. Thanks to your support of these funds, you are enhancing the training of our up-and-coming pathologists, improving the education of faculty from the earliest stages through senior levels, and providing opportunities for ongoing research as we work to find the underlying ca
FULL STORY
/static/apps/cms/news/1501/images/banners/Nunez Header Photo 2024_01.jpg

What is in your gut?

January 5, 2024 / Experimental Pathology

Dr. Gabriel Nunez 's Lab Makes Breakthrough Discovery in Colitis

FULL STORY
/static/apps/cms/news/1485/Rao_Ege_SQ.jpg

Grant funds research into childhood blindness, new partnership in Turkey

November 21, 2023 / Research

A Global REACH seed grant aims to bridge stem cell biology and cutting-edge 3D retinal organoid technology to inform new research of childhood diseases that cause blindness.

Rajesh C. Rao, M.D., Leonard G. Miller Professor of Ophthalmology and Visual Sciences, and Associate Professor of Human Genetics and Pathology, is a retina surgeon and physician-scientist. He garnered a $10,000 Partnership Development Grant last fall to collaborate with colleagues at the Ege University Faculty of Medicine, in Turkey, where the team was treating a very unique patient.

“This is just one of those needle-in-a-haystack situations. The disease the patient was suffering from, Strømme Syndrome, is so incredibly rare,” Rao said. “I’m really grateful that Global REACH [...]

FULL STORY
/static/apps/cms/news/1484/RobertaCaruso-sq 500.jpg

Study provides mechanistic link of diet to inhibition of colitis in Crohn's disease

November 16, 2023 / Experimental Pathology

Crohn’s disease (CD), one of the major forms of Inflammatory Bowel Disease, is a chronic relapsing intestinal disorder that affects millions of people globally. The cause of CD is unknown, but it is thought to result from a dysregulated immune response against environmental factors, including intestinal microbes, in genetically susceptible hosts.

The critical role that the intestinal microorganisms, collectively known as the gut microbiota, plays in the pathogenesis of CD has been investigated over the past two decades. Given the importance of the gut microbiota in triggering CD, the development of therapeutic approaches that target disease-causing intestinal microbes may provide a unique approach to the treatment of this disease [...]

FULL STORY
/static/apps/cms/news/1481/Untitled-1.png

22nd Annual Molecular and Cellular Pathology Research Symposium Held November 3rd

November 9, 2023 / Phd Program
On November 3rd in the Biomedical Science Research Building's Khan Auditorium, the 22nd Annual Pathology Research Symposium began. This year the symposium featured lectures, panel, and poster sessions from a variety of individuals from the Molecular and Cellular Pathology program, including Department of Pathology faculty, Michigan Medicine staff, and visiting professor and keynote speaker Charles Mullighan, MBBS (Hons), MSc, MD Departm
FULL STORY

Dr. Jeffrey B. Hodgin Among Team Awarded 2023 Global Team Science Award

August 2, 2023 / Award

Dr. Jeffrey B. Hodgin, MD, PhD among team members awarded the 2023 Global Team Science Award.

FULL STORY
/static/apps/cms/news/1427/DFB 2023 (500 × 500 px).jpg

9th Annual Developing Future Biologists Short Course is Underway

June 1, 2023 / Education

A week-long, all-expenses-paid trip to Ann Arbor, Michigan in late Spring may sound too good to be true, but for 30 fortunate undergraduate students from around the United States and its territories, this becomes a reality when they are accepted into the annual Developing Future Biologists (DFB) short course.

FULL STORY
/static/apps/cms/news/1416/Peter Ward 500.jpg

New Antibody Treatment Discovered by Ward Lab Approved by FDA

April 6, 2023 / Publications

After several decades of hard work by many scientists at the University of Michigan Medical School and elsewhere, an antibody (anti-C5a) has just been approved by the US FDA for treatment of humans who are septic and have developed lung infections with COVID-19, resulting in severe pulmonary dysfunction requiring external lung support. The antibody, anti-C5a, was originally developed in the Dr. Peter Ward laboratory in the early 2000s. The mAb was shown to dramatically reduce lung infections in polymicrobial sepsis in mice. 

FULL STORY
/static/apps/cms/news/1415/Dr_ Sem Phan and Tianju Liu 500.jpg

Idiopathic Pulmonary Fibrosis Research Discovery Published

April 5, 2023 / Publications

A recently published research study led by Drs. Sem Phan and Tianju Liu from the Department of Pathology reported new findings that could help scientists predict disease progression and suggest a new immunotherapy target for the treatment of IPF and other fibrotic lung diseases.

These findings uncovered a new role for the immune checkpoint marker (B7-H3) in lung fibrosis that can potentially serve as a novel target for immunotherapy to slow down or abort the progression of lung fibrosis in patients with IPF and other chronic lung fibrotic diseases. In addition, sB7H3 levels in the plasma could serve as a potential marker to predict how quickly the disease progresses in patients and assess responsiveness to therapy, allowing for more informed treatment decisions.

FULL STORY
/static/apps/cms/news/1407/images/banners/Giving-Bluesday-2023-Lg-Header-5.jpg

Pay it Forward

March 8, 2023 / Announcement

Giving Blueday, March 15, 2023

FULL STORY
/static/apps/cms/news/1403/Sahiti Marella 500.jpg

MCP Student Sahiti Marella shares her journey to becoming grant funded

March 8, 2023 / Phd Program

The Department of Pathology offers the Molecular and Cellular Pathology Graduate Program (MCP) for students who are interested in translational research – the step between basic science research and clinical care, the “bench-to-bedside” transition. Sahiti Marella is a graduate student in the MCP who was recently awarded her first F31 grant. This is an NIH-funded predoctoral grant that provides awardees with a monthly stipend to support tuition and fees, and funds for training-related costs while they conduct their PhD research project, for up to five-years of funding.

FULL STORY
/static/apps/cms/news/1400/David Hu Headshot (500x500).jpg

Identifying an “Achilles heel” of an aggressive subset of acute leukemias

February 17, 2023 / Phd Program

Hsiang-Yu (David) Hu, a Molecular and Cellular Pathology graduate student in the lab of Dr. Andrew Muntean recently published his first first-authored article in Leukemia.

FULL STORY
/static/apps/cms/news/1392/Mahnoor-cropped (002).png

International Day of Women and Girls in Science: Mahnoor Gondal

February 10, 2023 / Phd Program

At Michigan Medicine, many of our faculty serve across multiple departments, which opens up opportunities for students to also experience not just Pathology, but also other disciplines. The Department of Computational Medicine and Bioinformatics is one of the departments with which several of our Pathology faculty and students collaborate. In honor of the UN International Day of Women and Girls in Science, the DCMB featured one of our joint students as shared below.

FULL STORY
/static/apps/cms/news/1387/Asma Nusrat and Charles Parkos 500.jpg

Drs. Asma Nusrat and Charles Parkos Named 2022 AAAS Fellows

February 7, 2023 / Experimental Pathology

Congratulations are due to Dr. Asma Nusrat, F. Peyton Rous Professor of Experimental Pathology and Director of Experimental Pathology, and Dr. Charles Parkos, Carl V. Weller Professor and Chair of Pathology, on being named 2022 American Association for the Advancement of Science Fellows. The AAAS is the world’s largest general scientific society and publisher of the Science family of journals. The 2022 class was comprised of 505 scientists, engineers and innovators from around the world and across all disciplines.  Being selected as an AAAS Fellow is one of the most distinguished honors within the scientific community. The newly elected Fellows are being recognized for their scientific and socially notable achievements spanning their careers.

FULL STORY
/static/apps/cms/news/1385/Chang_Kim-1 500.jpg

Kim lab identifies the niche and mobilization mechanism for bone marrow innate lymphoid cell progenitors

January 25, 2023 / Publications

The laboratory of Dr. Chang Kim, recently published a high-impact study that elucidates the bone marrow niche and mechanisms by which innate lymphoid cells differentiate between those which remain in the bone marrow and those which emigrate to the rest of the body.  Read more[...]

FULL STORY
/static/apps/cms/news/1384/Riccardo_Valdez 500 X 500.jpg

Study Published on Effectiveness of the Omicron Bivalent Booster

January 18, 2023 / Clinical Pathology

As the SARS-CoV-2 virus continues to mutate over time and new booster vaccines become available, the question arises, are the multivalent boosters more effective at improving immune response than the monovalent vaccines with which we began? This question was addressed by a multi-site group from Columbia University Vagelos College of Physicians and Surgeons (New York) and from the University of Michigan Medical School Department of Pathology. Drs. Riccardo Valdez, Carmen Gherasim, and Aubree Gordon represented the Immunity Associated with SARS-CoV-2 (IASO) research team at U-M[...]

FULL STORY
/static/apps/cms/news/1357/Research-Faculty-Symposium-2023-SQ.jpg

Research Faculty Symposium 2023

November 7, 2022 / Events

The inaugural Research Track Faculty Symposium will be held on Thursday, March 23rd, 2023. Abstract submission deadline is Friday, December 16th. 

Register Now

 

FULL STORY
/static/apps/cms/news/1338/images/banners/Nunez-Header-LG.jpg

30 Years of Research at Michigan Medicine

November 4, 2022 / Experimental Pathology

Walk through a 30-year career with Dr. Gabriel Nunez--highlighting his key discoveries, perspectives on work/life balance, and those he mentored.

FULL STORY
/static/apps/cms/news/1355/Cantley_Richard_500sq.jpg

Cytomorphology and IHC helps diagnose transformed metastatic prostate cancer

October 27, 2022 / Experimental Pathology

A research team from the Michigan Center for Translational Pathology undertook a study to illustrate how careful assessment of cytologic and biomarker features may provide physicians with information on Metastatic Prostatic Cancer (MCP) patients’ prognosis and the best therapies to consider [...]

FULL STORY
/static/apps/cms/news/1305/images/banners/Feature Image Parkos_Nusrat_Lab-18.jpg

What is a Research Lab Manager?

June 20, 2022 / Experimental Pathology

...and what do they do?

FULL STORY
/static/apps/cms/news/1237/images/banners/New-Banner-Miller.jpg

Careers in Pathology: Aging Research

April 5, 2022 / Experimental Pathology

Dr. Richard Miller candidly describes his career progression in aging research.

FULL STORY
/static/apps/cms/news/1239/USCAP_Story_500x500.jpg

Department of Pathology Soars at USCAP 2022

April 1, 2022 / Education

This month marked the usual United States and Canadian Academy of Pathology (USCAP)'s Annual Meeting. This year's hybrid-style event, the 11th annual, was held both in-person and virtually in Los Angeles, California from March 18-24, 2022. The symposium featured several short and long courses, as well evening specialty conferences and ticketed seminars. The conference also included numerous poster sessions, live Q&A segments, and a multitude of social events [...]

FULL STORY
/static/apps/cms/news/1231/images/banners/Admin-Header-LG.jpg

Careers in Pathology: Research Administration

March 21, 2022 / Staff

Meet the members of the Research Administration team within the Department.

FULL STORY
/static/apps/cms/news/1232/images/banners/Parkos-Header-LG.jpg

Dr. Charles Parkos

March 10, 2022 / Faculty Spotlight

Reflections on the Future of Pathology

FULL STORY
/static/apps/cms/news/1228/Chinnaiyan 500 x 500.jpg

Arul Chinnaiyan, MD, PhD, selected for the Sjöberg Prize in Cancer Research

February 11, 2022 / Award

The Royal Swedish Academy of Sciences, which also awards the Nobel Prizes, announced today that Arul Chinnaiyan, MD, PhD, S.P. Hicks Professor of Pathology and Urology at Michigan Medicine and Director of the Michigan Center for Translational Pathology, has been selected as [...]

FULL STORY
/static/apps/cms/news/1221/Chelsea Phillips_500 x 500.jpg

Graduate Student Chelsea Phillips Research Recognitions

January 26, 2022 / Award

Congratulations to Chelsea Phillips, a graduate student in the Neurosciences graduate program, mentored by Dr. Anuska Andjelkovic-Zochowski, for two honors received on her work [...]  

FULL STORY
/static/apps/cms/news/1218/McCain_500x500.jpg

Research from INHERET Published in JNCCN

January 18, 2022 / Publications

Research from INHERET was just published in the Journal of the National Comprehensive Cancer Network (JNCCN). Learn more about this study, which analyzes the implementation of InheRET's online tool that provides information about family history as it relates to cancer risks [...]

FULL STORY
/static/apps/cms/news/1216/Taylor_500x500.jpg

Research Study Published in European Urology's Open Science

January 5, 2022 / Publications

 A multi-institutional study led by Drs. Alex Taylor, Noah Brown and Rohit Mehra from the Department of Pathology was just published in European Urology's Open Science. Learn more about the resarch, which focuses on how TERT promoter mutations were characterized in urinary tract lesions, which may be considered as precursors to neoplasia at this site [...]

FULL STORY
/static/apps/cms/news/1214/Cells-Microscopic-3D-Render-Particles-500x500.jpg

Study Demonstrates a Novel Approach to Target Enhancer-Addicted Cancers

January 4, 2022 / Video

A chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers.

FULL STORY
/static/apps/cms/news/1207/images/banners/Yin_Yang_Header_LG.jpg

The Yin and the Yang of Research in the COVID Era

December 20, 2021 / Newsletter

As COVID closed down research labs, researchers shifted focus.

FULL STORY
/static/apps/cms/news/1197/Ptaschinski_500x500.jpg

Study Finds that Microbiome Colonization During Infancy is Critical for Modulating Immunity Later in Life

October 29, 2021 / Experimental Pathology

A study related to the maternal gut microbiome and how it regulates immunity to respiratory syncytial virus (RSV) infections in offspring was recently published in the Journal of Experimental Medicine. Clinical experts from the Department of Pathology including Drs. Wendy Fonseca, Nicholas Lukacs, and Catherine Ptaschinski were responsible for carrying out this study [...]

FULL STORY
/static/apps/cms/news/1180/Harms_500x500.jpg

The Link Between Dysplastic Squamous Cells and Merkel Cell Carcinoma (MCC)

October 15, 2021 / Clinical Pathology

Research pertaining to Merkel cell carcinoma (MCC) and cutaneous neuroendocrine carcinomas was just published in the latest edition of Modern Pathology. Led by the team of Drs. Paul Harms, May Chan, Aaron Udager, Rajiv Patel, and more [...]

FULL STORY
/static/apps/cms/news/1165/Natarajan-Siva500x500.jpg

MCP Student Siva Kumar Natarajan Awarded Mistletoe Research Fellowship

August 25, 2021 / Award

Congratulations to Molecular and Cellular Pathology Graduate Student Siva Kumar Natarajan on being awarded the Mistletoe Research Fellowship (MRF).  Established in 2018, the Momental Foundation awards 20 MRF positions to exceptional postdoctoral fellows and advanced PhD candidates from the United States, Japan, and Singapore.

FULL STORY
/static/apps/cms/news/1152/Green-Blob-Spirals-Blue-Molecule-500x500.jpg

Researchers Develop First Inhibitors Against Key Epigenetic Complex Involved in Cancer

June 21, 2021 / Research

Activity of the polycomb repressive complex 1 is essential for the development and maintenance of leukemic cells; disrupting it presents a new potential therapeutic approach. Leukemia stem cells are rare cells that can renew themselves while continuing to generate malignant cells known as leukemic blasts. These cells are difficult to eradicate using chemotherapy drugs and frequently lead to recurrence of leukemia [...]

FULL STORY

Research Published in Urologic Oncology's ScienceDirect

June 10, 2021 / Clinical Pathology

Research by Drs. Alexander Taylor and Stephanie Skala seek to understand why tumors masquerade as forms of type-2 papillary of renal cell carcinoma. The study was just published in Urologic Oncology's ScienceDirect [...]

FULL STORY
/static/apps/cms/news/1140/Westerhoff_500x500.jpg

Coronavirus (COVID-19) Research Published in Archives of Pathology and Laboratory Medicine

May 18, 2021 / Anatomic Pathology

Research from the Department of Pathology was just published in the Archives of Pathology and Laboratory Medicine. Learn more about this publication, which highlights GI samples from COVID-19 patients, led by Dr. Maria Westerhoff [...]

FULL STORY
/static/apps/cms/news/1136/Lab_Note_500x500.jpg

Researchers Develop First-in-Class Inhibitors Against Key Leukemia Protein

May 17, 2021 / Michigan Health Blog

A research effort by Drs. Jolanta Grembecka and Tomasz Cierpicki was just published in Nature Communications. Learn more about the protein made by the ASH1L gene, which plays a key role in the development of acute leukemia, along with other diseases [...]

FULL STORY
/static/apps/cms/news/1135/Lombard_500x500.jpg

Research from Lombard Lab Published in Journal of Clinical Investigation

May 12, 2021 / Publications

Research from the Department's Lombard Lab was just published in the Journal of Clinical Investigation. The study, which focuses on how the deacylase SIRT5 compound supports melanoma viability by influencing chromatin dynamics, was led by Dr. Lombard [...]

FULL STORY
/static/apps/cms/news/1133/Broadening-the-Scope-Header-LG.jpg

Broadening the Scope: A Qualitative Study of Pathologists’ Attitudes Toward Patient-Pathologist Interactions

May 5, 2021 / Quality And Health Improvement

Learn more about pathologists' attitudes toward patient interactions in this new publication, led by Dr. Cathryn Lapedis.

FULL STORY
/static/apps/cms/news/1126/Cho_500x500.jpg

Research by Dr. Cho Published in AACR's "Cancer Research"

April 19, 2021 / Clinical Pathology

A new publication from the Department of Pathology, led by Dr. Kathleen Cho, was just published in the American Association for Cancer Research's flagship journal. highlights how altering the microbiome within a mouse model of oviductal high-grade serious carcinoma can inhibit tumorigeneis [...]

FULL STORY
/static/apps/cms/news/1121/Andi_Cani_500x500.jpg

New Assay For Early Detection of Aggressive Prostate Cancers Developed

April 13, 2021 / Clinical Pathology

A new study, led by U-M graduate in molecular and cellular pathology Dr. Andi Cani, was just published in European Urology Oncology. The publication focuses on the development of a whole-urine, multiplexed, next-generation RNA-sequencing assay that is used for the early detection of aggressive forms of prostate cancer [...]

FULL STORY

Department of Pathology Shines at 2021 Virtual USCAP Meeting

March 24, 2021 / Conferences

The Department of Pathology was well represented at the 110th Annual Meeting of the United States and Canadian Academy of Pathology (USCAP), held March 13-18, 2021. This year's event was reconstructed into a fully virtual format in response to the COVID-19 pandemic, with participants able to tune in and contribute from all over the world. Several of our faculty and trainees were featured at this year's conference. Let's take a moment to recap some key highlights from #USCAP2021.

FULL STORY
/static/apps/cms/news/1110/Dressler_500x500.jpg

Two Proteins Critical for Kidney Function

March 24, 2021 / Michigan Health Blog

Research by Drs. Ann Laszczyk and the Department of Pathology's Dr. Gregory Dressler was just published in the Journal of the American Society of Nephrology. The study focuses on PAX2 proteins and their effects on kidney function and development.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1057/Pitchiaya_500x500.jpg

Stressed Cellular Protein HOPS Into Action

February 16, 2021 / Experimental Pathology

Research team discovered that proteins with the capacity to multimerize quickly responded to osmotic changes (dehydration) caused by high saline or sugar concentrations, condensing into aggregates resembling processing bodies (P-bodies). The reaction, known as hyperosmotic phase separation, or HOPS, takes only a few seconds and is reversible within less than 2 minutes [...]

FULL STORY
/static/apps/cms/1100/Chang_Kim_500x500.jpg

Role of BATF in the Development of Innate Lymphoid Cells Elucidated

February 10, 2021 / Publications

A series of sophisticated processes are required in the development of innate lymphoid cells (ILC) for them to reach maturity. The Kim laboratory discovered that basic leucine zipper ATF-like transcription factor (Batf) regulates the production of ILC progenitors in the bone marrow as well as the maintenance of ILCs in the periphery. These cells are strategically distributed in peripheral tissues to provide important innate immunity to fight pathogens such as pathogenic viruses and bacteria.

FULL STORY

The multi-faceted role of the SUV family of H3K9 methyltransferases

February 8, 2021 / Clinical Pathology

A new study from Drs. Andrew Muntean and Nirmalya Saha of the Department of Pathology's Muntean Lab was just published in Biochim et Biophysica (BBA) Reviews on Cancer. The research project sheds light on the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and within cancer progression.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1096/Udager_500x500.jpg

Research from Dr. Udager Published in European Urology

February 1, 2021 / Publications

A new publication, generated by Department of Pathology faculty members Drs. Aaron Udager and Scott Tomlins was successfully published in European Urology. The research highlights a longitudinal cohort study centered around the serial molecular profiling of low-grade prostate cancer in order to better assess tumor upgrading [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1087/Liver_Story_500x500.jpg

Study Explains Why Patients with Cancer Spread to the Liver Have Worse Outcomes

January 5, 2021 / Experimental Pathology

A new study by the University of Michigan's Rogel Cancer Center analyzed patients with cancer and the factors that cause the cancer to spread to the liver, leading to worse outcomes. 

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1084/man-looking-in-microscope-500x500.jpg

Prostate Cancer Regulator Plays Role in COVID-19, Providing a Promising Treatment Lead

December 22, 2020 / Michigan Health Blog

Clinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus. wo proteins, ACE2 and TMPRSS2, help the coronavirus gain entry and replicate within cells. TMPRSS2 is well-known to Arul Chinnaiyan, MD, PhD. His lab discovered that TMPRSS2 fuses with the ETS gene to drive more than half of all prostate cancers [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1080/GREMBECKA_500X500.jpg

Research Led by Drs. Cierpicki and Grembecka Published in "Blood"

December 2, 2020 / Clinical Pathology

A new study led by Drs. Jolanta Grembecka and Tomasz Cierpicki of the Department of Pathology was just published in Blood's American Society of Hematology. The research focuses on combinatorial treatment with menin and FLT3 and how inhibitors induce complete remission in acute myeloid leukemia (AML) with activating FLT3 mutations [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1075/UDAGER_500x500.jpg

Research Led by Dr. Udager Published in Modern Pathology

November 19, 2020 / Clinical Pathology

New research by the Department of Pathology was recently published in Modern Pathology. The study, led by Drs. Aaron Udager, Noah Brown, Bryan Betz, Jonathan McHugh and Scott Tomlins, focuses on how TP53 mutations and CDKN2A mutations and deletions are highly recurrent molecular alterations within malignant progression of sinonasal papilomas [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1074/Kleer_500x500.jpg

Dr. Celina Kleer Wins ASIP 2020 Outstanding Investigator Award

November 12, 2020 / Experimental Pathology

Congratulations to Dr. Celina Kleer who was awarded the American Society for Investigative Pathology (ASIP)'s 2020 Outstanding Investigator Award. Dr. Kleer receives the award for her demonstrated excellence in research in experimental pathology [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1066/Miller_500x500.jpg

Study Regarding Inhibition of Class I PI3K Published in Journal of Cell Biology

October 30, 2020 / Publications

Research by the Department of Pathology's Drs. Richard Miller and Joseph Endicott was just published in the Journal of Cell Biology. The study focuses on the inhibition of class I PI3K and how it enhances chaperone-mediated autophagy (CMA) [...]

FULL STORY

Host-Microbiota Interactions in Health and Disease: Gabriel Nunez, MD

October 20, 2020 / Events

12:00 pm EST

Join #UMichPath and the University of Pennsylvania's Perelman School of Medicine for a virtual event with department faculty Dr. Gabriel Nuñez, who will be hosting a discussion related to host-microbiota interactions in modern health and disease.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1065/Piazza_500x500.jpg

Michigan Medicine Highlights Phlebotomy Research on Podcast

October 20, 2020 / Quality And Health Improvement

Experts from the Department of Pathology's Phlebotomy Team were featured on Michigan Medicine's "The Wrap" podcast. The podcast focuses on the department's Poke Plan Program at C.S. Mott Children's Hospital, an initiative that helps to alleviate pain and fear among children during the blood draw process [...]

FULL STORY

Bad Bacteria Make Their Own Food to Colonize the Gut

October 16, 2020 / Experimental Pathology

Diarrhea can be the unfortunate but short-lived side effect of bad takeout food, yet it is also a leading cause of death in children under five globally. Scientists continue to investigate how illness-causing bacteria gain a foothold within the digestive tract when they are usually held in check by the protective bacteria collectively known as the gut microbiome [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1061/Kleer_500x500_2.jpg

Understanding Breast Cancer: My Journey as a Physician-Scientist: Celina Kleer, MD

October 9, 2020 / Events

10:00 am EST

Join us for a virtual event featuring the Department of Pathology's Dr. Celina Kleer, who will host a discussion related to her experiences in understanding breast cancer and her journey as a physician-scientist.

Register Now

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1060/Arul_500x500.jpg

ASIP Rous-Whipple Award Lecture: Arul Chinnaiyan, MD, PhD

October 1, 2020 / Events

11:30 am EST

Join us for a virtual event featuring the Department of Pathology's Dr. Arul Chinnaiyan, who will give the 2020 American Society for Investigative Pathology (ASIP)'s Rous-Whipple Award Lecture. 

Register Here

 

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1059/Hristov_500x500.jpg

Research By Dr. Hristov Published in Journal of Cutaneous Pathology

October 1, 2020 / Publications

New research from the Department of Pathology and Dr. Alexandra Hristov was just published in the Journal of Cutaneous Pathology. The study focuses on the kappa and lambda immunohistochemistry in situ hybridization of atypical cutaneous lymphoid infiltrates. 

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1048/500x500_MM_Image.jpg

Scientists Develop First Drug-Like Compounds to Inhibit Elusive Cancer-Linked Enzymes

September 2, 2020 / Michigan Health Blog

Structural biology techniques helped researchers target the nuclear receptor-binding SET domain family, whose malfunction is associated with several types of cancer.

FULL STORY

Research Surrounding H3K27M-mutant diffuse midline glioma in COVID-19 Published

July 7, 2020 / Experimental Pathology

New research related to H3K27M-mutant diffuse midline glioma with extensive intratumoral microthrombi in young adults with COVID-19 from the Department of Pathology was just published in Acta Neurologica. [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1032/Difeo_500x500.jpg

Research Surrounding miR-181a Published

June 25, 2020 / Experimental Pathology

Research from Dr. Analisa Difeo was just published in Nature Communications. The study focuses on miR-181a and how it initiates and perpetuates oncogenic transformation through the regulation of innate immune signaling [...]

FULL STORY

Forensic Research Regarding COVID-19 Published

June 18, 2020 / Experimental Pathology

The publication takes an in-depth examination of diffuse alveolar damage (DAD) caused by COVID-19 and how it is morphologically indistinguishable from other causes of DAD.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1005/Lab_500x500.jpg

U-M Researchers Home in on Key Player in Pancreatic Cancer Development

June 4, 2020 / Experimental Pathology

The protein Argonaute 2 was found to be critical to the progression from benign lesions into pancreatic cancer, suggesting a therapeutic opportunity.

FULL STORY

Research Regarding Invasive Squamous Cell Carcinoma Published

May 29, 2020 / Experimental Pathology

The research, which focuses on invasive squamous cell carcinomas and the precursor lesions that demonstrate concordic genomic complexity in driver genes, was just published in Modern Pathology.

FULL STORY
/static/apps/cms/news/956/Rohit-Header-LG-Apr14-2020.jpg

Diagnostic Biomarkers Uncovered for Rare Kidney Cancer

April 21, 2020 / Experimental Pathology

Researchers have uncovered the gene signature for ChRCC.

FULL STORY
/static/apps/cms/news/942/Mucosal-Header-Lg.jpg

Department Co-Hosts 2020 Mucosal Immunology Symposium

March 13, 2020 / Conferences

The event showcased experiemental pathology research.

FULL STORY
/static/apps/cms/news/922/CHAMP-Header-LG.jpg

Department Hosts 11th Annual CHAMP Research Symposium

February 17, 2020 / Conferences

Event showcases clinical and translational research.

FULL STORY
/static/apps/cms/news/921/grembecka-921-Header-LG.jpg

Anti-Leukemia Compound Induces Complete Remission in Mouse Models

February 3, 2020 / Experimental Pathology

A Phase I clinical trial, using a structurally related analog of the compound, is currently enrolling patients.

FULL STORY

Results of Michigan-Led Study Published in Modern Pathology

January 23, 2020 / Publications

Modern Pathology recently published a multi-institutional study led by pathology faculty Dr. Rohit Mehra; other participating centers included The Cleveland Clinic, Emory School of Medicine and Memorial Sloan Kettering Cancer Center. Third year Pathology resident at Michigan Medicine, Alex Taylor, MD, was the first author with other major contributions by Drs. Noah Brown and May Chan. [...]

FULL STORY
/static/apps/cms/news/896/Twist-of-Cell-Fate-896-Header-LG.jpg

A Simple Twist of Cell Fate

January 15, 2020 / Experimental Pathology

U-M researchers are shedding new light with exciting implications for research and health.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/886/Venneti_Lab_Chan.jpg

Dr. Chan Chung Receives Two Grants to Study Brain Cancers

January 9, 2020 / Experimental Pathology
 

Chan Chung, PhD, received two grants in funding from the ChadTough Foundation and Defeat DIPG foundation ($150,000) and the Robert Connor Dawes CERN Pediatric Fellowship ($100,000). [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/889/nih-sq.jpg

Updated NIH Policy Statement Emphasizes "Other Support" Reporting

December 20, 2019 / Announcement

All faculty who serve as the Principal Investigator or one of the key personnel on an NIH award or pending proposal are required to review their new guidance and address the two parts below, as appropriate, by January 20, 2020 [...]

FULL STORY

R01 Granted to Jolanta Grembecka, PhD

December 20, 2019 / Award

We are thrilled to announce that Jolanta Grembecka, PhD, an Associate Professor in Pathology, has been granted an R01 for her research “Development of ASH1L inhibitors for acute leukemia.” [...]

FULL STORY
/static/apps/cms/878/Parolia_Abhijit_sq.jpg

Abhijit Parolia is Awarded The NCI Predoctoral to Postdoctoral Fellow Transition Award

December 2, 2019 / Announcement
 

The National Cancer Institute’s (NCI) Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award supports outstanding PhD and other Research Doctoral candidates who complete their dissertation research training (F99 phase) and transition in a timely manner to mentored, cancer-focused postdoctoral career development research positions (K00 phase). [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/857/Mark_Schultz-7.jpg

Results from the Andrew P. Lieberman Lab are Published

November 20, 2019 / Announcement

Mark Schultz, PhD, and Andrew Lieberman MD, PhD, have published “Synthetic high-density lipoprotein nanoparticles for the treatment of Niemann–Pick diseases” in BMC Medicine. [...]

FULL STORY
/static/apps/cms/856/Malinczak_Carrie-Anne-SQ.jpg

From Carrie-Anne to Dr. Malinczak

November 12, 2019 / Phd Program

Carrie-Anne Malinczak, PhD successfully defended her thesis entitled “Long-Term Immune System Alterations Following Early-Life RSV Infection” on October 21, 2019. Respiratory syncytial virus (RSV), a ubiquitous human pathogen, infects nearly all children by age two. Severe RSV bronchiolitis in infancy is strongly correlated with the development of recurrent wheezing later in childhood [...]

FULL STORY
/static/apps/cms/news/855/Engaging-Future-Header-855-LG.jpg

Engaging Our Future

November 8, 2019 / Publications

Department faculty outreach to high school students to educate about careers in medicine and research.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/812/Kumar_Pablove_SQ.jpg

Dr. Surinder Kumar Receives The Pablove Foundation Childhood Cancer Research Grant

September 18, 2019 / Experimental Pathology

Surinder Kumar, Ph.D., has received The Pablove Foundation Childhood Cancer Research Grant for his proposal entitled “The sirtuin SIRT5 as a novel therapeutic target for Ewing’s Sarcoma” [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/816/Westerhoff-Rare-Complication.jpg

Dr. Maria Westerhoff Publishes in Gastroenterology

August 20, 2019 / Publications

In collaboration with Drs. Luke Nayak and Arjun Sondhi, Dr. Maria Westerhoff published a report in Gastroenterology titled, "A Rare Complication of a Rare Disease" documents a case of erythropoietic protoporphyria, a rare condition that can affect the liver [...]

FULL STORY
/static/apps/cms/news/782/Chinnaiyan-blog-Header-LG.jpg

U-M Compounds Show Promise in a Lab Model of Advanced Prostate Cancer

May 14, 2019 / Experimental Pathology

A new study finds that U-M-designed compounds led to significantly smaller, slower-growing tumors.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/781/Grembecka_Jolanta_.jpg

Jolanta Grembecka, PhD, Among 14 Inaugural Rogel Scholars

May 14, 2019 / Experimental Pathology

Congratulations to Jolanta Gembecka, PhD, who is one of fourteen in the inaugural class of Rogel Scholars!  As part of the commitment from Richard and Susan Rogel, researchers will have the opportunity and freedom to pursue new directions in their work. Dr. Grembecka's research focus is developing [...]

FULL STORY
/static/apps/cms/news/770/UGD-MCTP-Header-Lg.jpg

Witnessing the dance of RNAs around droplets of cellular degradation machinery

April 3, 2019 / Experimental Pathology

If a picture's worth a thousand words, a video is perhaps worth much more.

FULL STORY
/static/apps/cms/news/759/schultz-header-lg.jpg

Creating Hope

February 18, 2019 / Experimental Pathology

Mark Schultz, PhD strives to create therapeutics for Niemann-Pick disease.

FULL STORY
/static/apps/cms/news/757/circRNA-Biomarker-Header-LG.jpg

Circular RNA Holds Promise as Cancer Biomarker

February 7, 2019 / Experimental Pathology

Unique structure of circRNA makes it an ideal candidate for biomarkers – and it can be detected in blood or urine.

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/699/dou-article.jpg

Work from the Dou and Dressler Labs highlighted in Cancer Cell

October 9, 2018 / Research

The laboratories of Dr. Yali Dou and Dr. Gregory Dressler have collaborated with colleagues at the National Institutes of Health, the Sloan Kettering Cancer Center, the Dana Farber Cancer Institute, and Indiana University to publish HOXA9 Reprograms the [...]

FULL STORY
/static/apps/cms/news/610/Genome-dark-matter-art_Header-LG.jpg

Genome's Dark Matter Sheds Light on Prostate Cancer Challenge

June 1, 2018 / Experimental Pathology

Researchers identify a lncRNA that provides insight into a key driver of prostate cancer — and a potential target for future therapy.

FULL STORY